当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析 - 现金流量表

冠昊生物

(300238)

  

流通市值:32.61亿  总市值:32.61亿
流通股本:2.65亿   总股本:2.65亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金101,005,829.08444,379,920.39327,735,041.46213,008,492.08
  收到的税费返还39,644.43---
  收到其他与经营活动有关的现金3,109,188.6611,750,433.29,845,710.897,810,201.45
  经营活动现金流入小计104,154,662.17456,130,353.59337,580,752.35220,818,693.53
  购买商品、接受劳务支付的现金14,873,172.4378,336,830.752,078,873.1432,258,121.11
  支付给职工以及为职工支付的现金35,699,094.72104,379,620.0384,693,045.1254,933,456.83
  支付的各项税费33,573,913.8544,734,229.6333,297,221.8523,927,704.18
  支付其他与经营活动有关的现金33,832,621.31157,205,877.47114,875,772.0770,420,283.16
  经营活动现金流出小计117,978,802.31384,656,557.83284,944,912.18181,539,565.28
  经营活动产生的现金流量净额-13,824,140.1471,473,795.7652,635,840.1739,279,128.25
二、投资活动产生的现金流量:
  收回投资收到的现金1,500,0003,142,712.17--
  取得投资收益收到的现金38,542.15---
  处置固定资产、无形资产和其他长期资产收回的现金净额41,12034,979.1727,914.3527,914.35
  投资活动现金流入小计1,579,662.153,177,691.3427,914.3527,914.35
  购建固定资产、无形资产和其他长期资产支付的现金11,898,993.6938,170,095.1529,590,534.7524,535,775.08
  投资支付的现金-300,000--
  取得子公司及其他营业单位支付的现金-898,382.18300,000898,382.18
  支付其他与投资活动有关的现金--898,382.18-
  投资活动现金流出小计11,898,993.6939,368,477.3330,788,916.9325,434,157.26
  投资活动产生的现金流量净额-10,319,331.54-36,190,785.99-30,761,002.58-25,406,242.91
三、筹资活动产生的现金流量:
  吸收投资收到的现金-6,101,3006,101,3006,101,300
  其中:子公司吸收少数股东投资收到的现金--6,101,300-
  取得借款收到的现金11,269,958.7745,013,50035,950,00024,000,000
  筹资活动现金流入小计11,269,958.7751,114,80042,051,30030,101,300
  偿还债务支付的现金1,591,417.320,010,00020,000,0002,000,000
  分配股利、利润或偿付利息支付的现金913,173.143,669,240.932,815,202.781,941,819.45
  支付其他与筹资活动有关的现金761,199.556,417,169.514,056,317.983,451,605.57
  筹资活动现金流出小计3,265,789.9930,096,410.4426,871,520.767,393,425.02
  筹资活动产生的现金流量净额8,004,168.7821,018,389.5615,179,779.2422,707,874.98
四、汇率变动对现金及现金等价物的影响-241,730.26-182,486.94-103,782.15-113,482.72
五、现金及现金等价物净增加额-16,381,033.1656,118,912.3936,950,834.6836,467,277.6
  加:期初现金及现金等价物余额160,602,712.5104,483,800.11104,483,800.11104,483,800.11
  期末现金及现金等价物余额144,221,679.34160,602,712.5141,434,634.79140,951,077.71
补充资料:
  净利润-14,787,270.04-16,512,890.17
  资产减值准备-3,186,786.42-1,736,227.74
  固定资产和投资性房地产折旧-12,466,350.34-6,267,314.08
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-12,466,350.34-6,267,314.08
  无形资产摊销-8,413,414.1-4,013,956.34
  长期待摊费用摊销-954,754.68-503,609.34
  处置固定资产、无形资产和其他长期资产的损失-5,119.4-5,569.63
  固定资产报废损失-76,038.05-12,808.87
  财务费用-4,035,969.72-2,167,804.25
  投资损失--1,894,614.62--143,125
  递延所得税--593,785.1--352,617.19
  其中:递延所得税资产减少-761,436.24-221,555.25
    递延所得税负债增加--1,355,221.34--574,172.44
  存货的减少--625,486.88-4,468,165.58
  经营性应收项目的减少-17,760,909.56-411,121.83
  经营性应付项目的增加-8,129,854.08-1,254,118.81
  现金的期末余额-160,602,712.5-140,951,077.71
  减:现金的期初余额-104,483,800.11-104,483,800.11
  现金及现金等价物的净增加额-56,118,912.39-36,467,277.6
公告日期2026-04-292026-03-262025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑